SCHALL MICHAEL J

Director Schall purchases 10,000 PEB shares at $10.85; stock down 29.6% from 52-week high, company unprofitable

Michael J. Schall, a director, purchased 10,000 shares of Pebblebrook Hotel Trust at $10.85 on 2025-11-19, increasing his holdings by 9.1% to 119,693 shares. The buy occurs at a price 29.6% below the 52-week high, while the company faces fundamental headwinds: latest-quarter revenue is $398.7M but net income was $-33.1M, with full-year results also unprofitable. Schall's prior trades at PEB show mixed timing—two of three prior buys achieved positive 90-day returns (+21.1% and +9.1% respectively), though one underperformed significantly (-29.0% over 30 days). His cross-ticker track record shows 4 prior buys averaging -0.8% over 90 days with a 75.00% win rate, suggesting moderate success timing entry points. At current price of $10.51, this purchase is already underwater by 3.1%, raising questions about whether the pullback reflects value or signals deeper operational challenges ahead.

Director Schall buys 10,000 shares of PEB at $10.08; stock now at -33.1% from 52-week high of $14.94

Michael J. Schall, a Director, purchased 10,000 shares at $10.08 on 2025-08-19, expanding his holdings to 109,693 shares (109.7K shares) from 99,693 shares (99.7K shares). The purchase occurs while Pebblebrook Hotel Trust trades 33.1% below its 52-week high of $14.94, following a recent 6.3% 30-day decline, though the stock is up 12.7% over 90 days. At the same ticker, Schall's prior buy on 2025-05-07 delivered a 90-day return of +9.1%, while his earlier buy on 2025-03-05 declined -22.8% over 90 days, showing mixed outcomes at PEB. The company maintains profitability on a quarterly basis ($18.1M net income on $407.5M quarterly revenue) but was unprofitable on a full-year basis, and annual revenue growth stands at a modest +2.4%.

Director Schall buys 10,000 PEB shares at $9.04; stock down 41.4% from 52-week high, company unprofitable ($-32.9M net income)

Director Michael J. Schall purchased 10,000 shares at $9.04 on 2025-05-07, increasing his stake from 8,500 to 18,500 shares. The transaction occurs after the stock has declined 41.4% from its 52-week high of $15.33 and while the company reported negative net income of $-32.9M in its latest fiscal year. Schall's prior buy at PEB (2025-03-05) posted a 30-day loss of 29.0%, and his cross-ticker track record shows 2 prior buys averaging -13.1% 30-day returns, with no well-timed trades at the 90-day mark. The current purchase at a depressed price level following a significant drawdown coincides with the company's profitability challenges and this insider's pattern of unfavorable near-term outcomes on similar transactions.

Director Michael J. Schall bought 4,000 shares of NSA at $38.54, tripling holdings to 6,000 shares totaling $154.2K.

Director Michael J. Schall purchased 4,000 shares at $38.54 on 2025-03-06, increasing his holdings from 2,000 to 6,000 shares—a +200.0% increase in his position. This represents a material personal commitment of $154,160.00. The purchase price of $38.54 sits below the current price of $39.59 and well below the 52-week high of $49.13, suggesting entry near recent lows. NSA is priced at a P/E of 25.54 with a $3.0B market cap, but faces headwinds: annual revenue has contracted -10.2% year-over-year, and the stock is -19.4% below its 52-week peak. With only 1 prior buy in his cross-ticker track record, this significant accumulation by a director at a time of revenue contraction warrants investor scrutiny into the company's near-term outlook and management's assessment of intrinsic value relative to market conditions.

Director Michael Schall buys 10,000 shares of PEB at $11.87; stock down 27.9% from 52-week high.

Director Michael Schall purchased 10,000 shares at $11.87, increasing his holdings by 11.1% to 99,693 shares. The transaction occurs as the stock trades 27.9% below its 52-week high of $16.46 and has declined 18.6% over the past 90 days. While the company generated $404.5M in quarterly revenue with a 2.4% annual growth rate, it posted negative full-year net income despite reporting $43.7M in latest quarterly net income, indicating earnings volatility or back-half losses. The buy signal must be weighed against this underlying profitability concern and sustained recent weakness.